Review summary
Teaching objective: Hypertensive heart disease and sudden cardiac death risk in a man whose job is physical: a 50-year-old professional boxing referee and boxing instructor, a former champion who lost his savings years ago and works to rebuild them, is found at his license examination to have stage 2 hypertension, with breathlessness and chest tightness late in long nights in hot arenas and left ventricular hypertrophy on the ECG. The episode covers the evaluation of exertional symptoms with exercise stress echocardiography under the 2021 AHA/ACC chest pain guideline; telling hypertensive hypertrophy from hypertrophic cardiomyopathy and athlete's heart; sudden cardiac death risk in left ventricular hypertrophy; a coronary calcium score that changes the statin decision under the 2026 ACC/AHA dyslipidemia guideline and the 2023 chronic coronary disease guideline; a two-drug single-pill start, home blood pressure monitoring, laboratory checks after each change and a target below 130/80 mmHg under the 2025 AHA/ACC blood pressure guideline; volume depletion on a thiazide in summer heat, sick-day rules and a change to a calcium channel blocker; aspirin by shared decision; a return-to-work plan for refereeing, with heat, hydration, warning symptoms and defibrillators at the venue; and financial strain and worry as social factors in care, with low-cost generic once-daily medicines.
Historical timeline
| Date | Event | Claims |
|---|---|---|
| April 7, 1896 | Born Benjamin Leiner in New York City to Orthodox Jewish immigrants from Russia. | CLM-0001 |
| about 1911 | Begins fighting professionally as Benny Leonard, keeping it from his parents. | CLM-0002 |
| May 28, 1917 | Wins the world lightweight championship from Freddie Welsh. | CLM-0003 |
| January 1925 | Retires as undefeated lightweight champion, at his mother's wish, wealthy and unmarked. | CLM-0003, CLM-0005, CLM-0004 |
| 1929 | Loses most of his savings in the stock market crash. | CLM-0006 |
| October 1931 | Comes back as a welterweight at 35; knocked out by Jimmy McLarnin in October 1932 and retires for good. | CLM-0006 |
| 1943 | Serving in the U.S. Maritime Service; returns to boxing as a referee in New York and teaches boxing at City College. | CLM-0007, CLM-0008 |
| April 18, 1947 | Collapses and dies in the ring at St. Nicholas Arena while refereeing, at 51; the cause is given as a heart attack in most sources and a cerebral hemorrhage in one. | CLM-0009, CLM-0010 |
Evidence claims
D = documented, R = retrospective, S = synthetic.
| Grade | Claim | Certainty | Sources |
|---|---|---|---|
| D | Benjamin Leiner was born on April 7, 1896, in New York City, to Gershon Leiner, a tailor, and Minnie Leiner, Orthodox Jewish immigrants from Russia, and grew up on the Lower East Side of Manhattan. | confirmed | Leonard, Benny (Scribner Encyclopedia of American Lives, Thematic Series: Sports Figures) supports Benny Leonard (Albert Davis Collection boxing exhibit) supports Wright S. Benny Leonard (Research Starters: Biography) supports HISTMED Master Roster v3 context |
| D | He began fighting professionally at about fifteen and took the name Benny Leonard to keep his boxing secret from his parents, because boxing was not thought a respectable living in their community. | confirmed | Leonard, Benny (Scribner Encyclopedia of American Lives, Thematic Series: Sports Figures) supports Benny Leonard (Albert Davis Collection boxing exhibit) supports Greenspan B. The Long Last Night in the Ring for Benny Leonard. The New York Times, April 10, 1983 (reprinted by the International Boxing Research Organization) supports |
| D | He won the world lightweight championship from Freddie Welsh on May 28, 1917, and held it until he retired as undefeated champion in January 1925, at his mother's wish. Anchors the synthetic modern history of a long career in the ring. |
confirmed | Benny Leonard (Class of 1979) supports Wright S. Benny Leonard (Research Starters: Biography) supports Benny Leonard (Albert Davis Collection boxing exhibit) supports Leonard, Benny (Scribner Encyclopedia of American Lives, Thematic Series: Sports Figures) supports |
| D | The son of Orthodox Jews, he never fought on a Jewish holiday and became a symbol of the acceptance of Jews in American life at a time of open antisemitism; the newspaper editor Arthur Brisbane wrote that he had done more to conquer anti-Semitism than a thousand textbooks. He later supported the Maccabiah Games. Documented identity recorded with respect; anchors the synthetic modern note that visits are not booked on the major Jewish holidays. |
confirmed | Leonard, Benny (Boxing) supports Benny Leonard (Albert Davis Collection boxing exhibit) supports Benny Leonard (Class of 1979) supports Wright S. Benny Leonard (Research Starters: Biography) supports |
| D | Retired, he had become wealthy; in his own words he was practically a millionaire, without a scratch. | confirmed | Greenspan B. The Long Last Night in the Ring for Benny Leonard. The New York Times, April 10, 1983 (reprinted by the International Boxing Research Organization) supports Leonard, Benny (Boxing) supports |
| D | He lost most of his savings in the 1929 stock market crash and in October 1931, at 35, came back as a welterweight; he won about nineteen fights in a row before Jimmy McLarnin knocked him out in the sixth round in October 1932, and he retired for good. Anchors the synthetic modern social history of financial strain driving a return to hard physical work. |
confirmed | Wright S. Benny Leonard (Research Starters: Biography) supports Benny Leonard (Class of 1979) supports Greenspan B. The Long Last Night in the Ring for Benny Leonard. The New York Times, April 10, 1983 (reprinted by the International Boxing Research Organization) supports Leonard, Benny (Scribner Encyclopedia of American Lives, Thematic Series: Sports Figures) supports HISTMED Master Roster v3 context |
| D | During the Second World War he served in the U.S. Maritime Service of the Merchant Marine, rising to lieutenant commander. | confirmed | Leonard, Benny (Scribner Encyclopedia of American Lives, Thematic Series: Sports Figures) supports Benny Leonard (Class of 1979) supports Wright S. Benny Leonard (Research Starters: Biography) supports |
| D | He returned to boxing as a referee of professional bouts in New York and also taught boxing at City College of New York. Anchors the synthetic modern occupation and the return-to-work question about refereeing. |
confirmed | Benny Leonard (Class of 1979) supports Leonard, Benny (Scribner Encyclopedia of American Lives, Thematic Series: Sports Figures) supports Benny Leonard (Albert Davis Collection boxing exhibit) supports Wright S. Benny Leonard (Research Starters: Biography) supports |
| D | On April 18, 1947, at 51, after refereeing the whole card at St. Nicholas Arena in New York on a hot night in a smoke-filled hall, he slumped over the lower rope early in the first round of the last bout and sank to the canvas. The commission physician tried to revive him, and he was carried to the dressing room, where he was found to have died. Recorded on the timeline only, as documented history; the modern episode makes no claim about the cause. |
confirmed | Greenspan B. The Long Last Night in the Ring for Benny Leonard. The New York Times, April 10, 1983 (reprinted by the International Boxing Research Organization) supports Leonard, Benny (Scribner Encyclopedia of American Lives, Thematic Series: Sports Figures) supports Benny Leonard (Class of 1979) supports HISTMED Master Roster v3 context |
| R | His sudden death is described in most sources as a heart attack; one reference work gives a cerebral hemorrhage. No autopsy finding was found in the sources read, and no earlier heart disease is documented. Contested cause of death; kept off the problem list and out of the modern episode, which makes no retrospective diagnosis. The roster's cardiovascular disease lead is not documented before his death. |
disputed | Wright S. Benny Leonard (Research Starters: Biography) supports Benny Leonard (Albert Davis Collection boxing exhibit) supports Leonard, Benny (Boxing) supports Leonard, Benny (Scribner Encyclopedia of American Lives, Thematic Series: Sports Figures) disputes HISTMED Master Roster v3 context |
Modern synthetic problem list
| Grade | Problem | Clinical status | Verification | Placement | Historical claims |
|---|---|---|---|---|---|
| S | Breathlessness and tightness across the chest on exertion for about two months, late in long nights of refereeing in hot arenas, easing within a few minutes of rest; never at rest; no fainting, palpitations, orthopnea or ankle swelling; cause under evaluation with a cardiology consultation | resolved | confirmed | active | CLM-0008 |
| S | Stage 2 hypertension found at a yearly fitness examination for his referee's license (164/100 and 160/98 mmHg), with left ventricular hypertrophy by voltage on the ECG; untreated; home readings to follow | resolved | confirmed | active | CLM-0008 |
| S | Hypertensive heart disease without heart failure: concentric left ventricular hypertrophy (septum 13 mm, mass index 118 g/m2) with normal ejection fraction, grade 1 diastolic dysfunction, a mildly enlarged left atrium and an exaggerated blood pressure rise on exercise; no features of hypertrophic cardiomyopathy | active | confirmed | active | CLM-0008 |
| S | Coronary atherosclerosis found by coronary calcium scoring (Agatston score 186, about the 80th percentile for his age and sex), without angina and with no inducible ischemia on exercise stress echocardiography | active | confirmed | active | CLM-0008 |
| S | Hypercholesterolemia: LDL 160 mg/dL, HDL 44 mg/dL, lipoprotein(a) not raised; no diabetes | active | confirmed | active | |
| S | Volume depletion after refereeing a long card in a heat wave while taking losartan 100 mg with hydrochlorothiazide 25 mg: lightheaded on standing, with an orthostatic fall in blood pressure, a prerenal rise in creatinine to 1.44 mg/dL and potassium 3.3 mmol/L; no fainting, chest pain or arrhythmia | resolved | confirmed | active | CLM-0008 |
Synthetic outcome measures
| Grade | Date | Measure | Result | Coding |
|---|---|---|---|---|
| S | 2026-05-12 | Sodium [Moles/volume] in Serum or Plasma | 140 mmol/L Reference 135-146 mmol/L |
http://loinc.org · 2951-2 |
| S | 2026-05-12 | Potassium [Moles/volume] in Serum or Plasma | 4.1 mmol/L Reference 3.5-5.3 mmol/L |
http://loinc.org · 2823-3 |
| S | 2026-05-12 | Urea nitrogen [Mass/volume] in Serum or Plasma | 15 mg/dL Reference 7-25 mg/dL |
http://loinc.org · 3094-0 |
| S | 2026-05-12 | Creatinine [Mass/volume] in Serum or Plasma | 0.98 mg/dL Reference 0.7-1.3 mg/dL |
http://loinc.org · 2160-0 |
| S | 2026-05-12 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 93 mL/min/1.73 m² Reference >=60 mL/min/1.73 m² |
http://loinc.org · 98979-8 |
| S | 2026-05-12 | Glucose [Mass/volume] in Serum or Plasma | 96 mg/dL Reference 65-99 mg/dL |
http://loinc.org · 2345-7 |
| S | 2026-05-12 | Hemoglobin [Mass/volume] in Blood | 14.6 g/dL Reference 13.5-17.5 g/dL |
http://loinc.org · 718-7 |
| S | 2026-05-12 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 24 U/L Reference 7-55 U/L |
http://loinc.org · 1742-6 |
| S | 2026-05-12 | Hemoglobin A1c/Hemoglobin.total in Blood | 5.5% Reference <=5.6% |
http://loinc.org · 4548-4 |
| S | 2026-05-12 | Thyrotropin [Units/volume] in Serum or Plasma | 1.9 mIU/L Reference 0.4-4.5 mIU/L |
http://loinc.org · 3016-3 |
| S | 2026-05-12 | Albumin/Creatinine [Mass Ratio] in Urine | 22 mg/g{creat} Reference <=29 mg/g{creat} |
http://loinc.org · 9318-7 |
| S | 2026-05-12 | Cholesterol [Mass/volume] in Serum or Plasma | 234 mg/dL (high) Reference <=199 mg/dL |
http://loinc.org · 2093-3 |
| S | 2026-05-12 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 44 mg/dL Reference >=40 mg/dL |
http://loinc.org · 2085-9 |
| S | 2026-05-12 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 160 mg/dL (high) Reference <=99 mg/dL |
http://loinc.org · 13457-7 |
| S | 2026-05-12 | Triglyceride [Mass/volume] in Serum or Plasma | 150 mg/dL (high) Reference <=149 mg/dL |
http://loinc.org · 2571-8 |
| S | 2026-05-12 | Lipoprotein a [Moles/volume] in Serum or Plasma | 42 nmol/L Reference <=124 nmol/L |
http://loinc.org · 43583-4 |
| S | 2026-05-12 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 5 | http://loinc.org · 44261-6 |
| S | 2026-05-12 | Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] | 6 | http://loinc.org · 70274-6 |
| S | 2026-05-12 | Total score [AUDIT-C] | 2 | http://loinc.org · 75626-2 |
| S | 2026-05-26 | Sodium [Moles/volume] in Serum or Plasma | 139 mmol/L Reference 135-146 mmol/L |
http://loinc.org · 2951-2 |
| S | 2026-05-26 | Potassium [Moles/volume] in Serum or Plasma | 4 mmol/L Reference 3.5-5.3 mmol/L |
http://loinc.org · 2823-3 |
| S | 2026-05-26 | Urea nitrogen [Mass/volume] in Serum or Plasma | 16 mg/dL Reference 7-25 mg/dL |
http://loinc.org · 3094-0 |
| S | 2026-05-26 | Creatinine [Mass/volume] in Serum or Plasma | 1.04 mg/dL Reference 0.7-1.3 mg/dL |
http://loinc.org · 2160-0 |
| S | 2026-05-26 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 87 mL/min/1.73 m² Reference >=60 mL/min/1.73 m² |
http://loinc.org · 98979-8 |
| S | 2026-05-26 | Glucose [Mass/volume] in Serum or Plasma | 94 mg/dL Reference 65-99 mg/dL |
http://loinc.org · 2345-7 |
| S | 2026-05-26 | Left ventricular Ejection fraction | 62% Reference 52-72% |
http://loinc.org · 10230-1 |
| S | 2026-05-26 | Interventricular septum Thickness during diastole by US | 13 mm (high) Reference 6-10 mm |
http://loinc.org · 18154-5 |
| S | 2026-05-26 | Left ventricular Myocardial mass/Body surface area [Mass/Area] by US 2D | 118 g/m2 (high) Reference 49-115 g/m2 |
http://loinc.org · 77897-7 |
| S | 2026-05-26 | Left atrial End-systolic volume (by US.2D+Calculated by biplane method of disks)/Body surface area | 36 mL/m² (high) Reference 16-34 mL/m² |
http://loinc.org · 79984-1 |
| S | 2026-06-30 | Sodium [Moles/volume] in Serum or Plasma | 138 mmol/L Reference 135-146 mmol/L |
http://loinc.org · 2951-2 |
| S | 2026-06-30 | Potassium [Moles/volume] in Serum or Plasma | 3.9 mmol/L Reference 3.5-5.3 mmol/L |
http://loinc.org · 2823-3 |
| S | 2026-06-30 | Urea nitrogen [Mass/volume] in Serum or Plasma | 17 mg/dL Reference 7-25 mg/dL |
http://loinc.org · 3094-0 |
| S | 2026-06-30 | Creatinine [Mass/volume] in Serum or Plasma | 1.06 mg/dL Reference 0.7-1.3 mg/dL |
http://loinc.org · 2160-0 |
| S | 2026-06-30 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 84 mL/min/1.73 m² Reference >=60 mL/min/1.73 m² |
http://loinc.org · 98979-8 |
| S | 2026-06-30 | Glucose [Mass/volume] in Serum or Plasma | 95 mg/dL Reference 65-99 mg/dL |
http://loinc.org · 2345-7 |
| S | 2026-07-21 | Sodium [Moles/volume] in Serum or Plasma | 133 mmol/L (low) Reference 135-146 mmol/L |
http://loinc.org · 2951-2 |
| S | 2026-07-21 | Potassium [Moles/volume] in Serum or Plasma | 3.3 mmol/L (low) Reference 3.5-5.3 mmol/L |
http://loinc.org · 2823-3 |
| S | 2026-07-21 | Urea nitrogen [Mass/volume] in Serum or Plasma | 32 mg/dL (high) Reference 7-25 mg/dL |
http://loinc.org · 3094-0 |
| S | 2026-07-21 | Creatinine [Mass/volume] in Serum or Plasma | 1.44 mg/dL (high) Reference 0.7-1.3 mg/dL |
http://loinc.org · 2160-0 |
| S | 2026-07-21 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 57 mL/min/1.73 m² (low) Reference >=60 mL/min/1.73 m² |
http://loinc.org · 98979-8 |
| S | 2026-07-21 | Glucose [Mass/volume] in Serum or Plasma | 104 mg/dL (high) Reference 65-99 mg/dL |
http://loinc.org · 2345-7 |
| S | 2026-07-28 | Sodium [Moles/volume] in Serum or Plasma | 139 mmol/L Reference 135-146 mmol/L |
http://loinc.org · 2951-2 |
| S | 2026-07-28 | Potassium [Moles/volume] in Serum or Plasma | 4.1 mmol/L Reference 3.5-5.3 mmol/L |
http://loinc.org · 2823-3 |
| S | 2026-07-28 | Urea nitrogen [Mass/volume] in Serum or Plasma | 17 mg/dL Reference 7-25 mg/dL |
http://loinc.org · 3094-0 |
| S | 2026-07-28 | Creatinine [Mass/volume] in Serum or Plasma | 1.04 mg/dL Reference 0.7-1.3 mg/dL |
http://loinc.org · 2160-0 |
| S | 2026-07-28 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 86 mL/min/1.73 m² Reference >=60 mL/min/1.73 m² |
http://loinc.org · 98979-8 |
| S | 2026-07-28 | Glucose [Mass/volume] in Serum or Plasma | 95 mg/dL Reference 65-99 mg/dL |
http://loinc.org · 2345-7 |
| S | 2026-07-28 | Cholesterol [Mass/volume] in Serum or Plasma | 138 mg/dL Reference <=199 mg/dL |
http://loinc.org · 2093-3 |
| S | 2026-07-28 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 47 mg/dL Reference >=40 mg/dL |
http://loinc.org · 2085-9 |
| S | 2026-07-28 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 66 mg/dL Reference <=99 mg/dL |
http://loinc.org · 13457-7 |
| S | 2026-07-28 | Triglyceride [Mass/volume] in Serum or Plasma | 124 mg/dL Reference <=149 mg/dL |
http://loinc.org · 2571-8 |
| S | 2026-07-28 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 1 | http://loinc.org · 55758-7 |
| S | 2026-08-25 | Sodium [Moles/volume] in Serum or Plasma | 140 mmol/L Reference 135-146 mmol/L |
http://loinc.org · 2951-2 |
| S | 2026-08-25 | Potassium [Moles/volume] in Serum or Plasma | 4.4 mmol/L Reference 3.5-5.3 mmol/L |
http://loinc.org · 2823-3 |
| S | 2026-08-25 | Urea nitrogen [Mass/volume] in Serum or Plasma | 15 mg/dL Reference 7-25 mg/dL |
http://loinc.org · 3094-0 |
| S | 2026-08-25 | Creatinine [Mass/volume] in Serum or Plasma | 1.02 mg/dL Reference 0.7-1.3 mg/dL |
http://loinc.org · 2160-0 |
| S | 2026-08-25 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 88 mL/min/1.73 m² Reference >=60 mL/min/1.73 m² |
http://loinc.org · 98979-8 |
| S | 2026-08-25 | Glucose [Mass/volume] in Serum or Plasma | 93 mg/dL Reference 65-99 mg/dL |
http://loinc.org · 2345-7 |
| S | 2026-10-27 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 2 | http://loinc.org · 44261-6 |
| S | 2026-10-27 | Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] | 3 | http://loinc.org · 70274-6 |
Synthetic vital signs
| Date | Measure | Result | LOINC | Grade |
|---|---|---|---|---|
| 2026-05-12 | Body height | 165 cm | 8302-2 | S |
| 2026-05-12 | Body weight | 74.6 kg | 29463-7 | S |
| 2026-05-12 | Body mass index (BMI) [Ratio] | 27.4 kg/m2 | 39156-5 | S |
| 2026-05-12 | Systolic blood pressure | 164 mm[Hg] | 8480-6 | S |
| 2026-05-12 | Diastolic blood pressure | 100 mm[Hg] | 8462-4 | S |
| 2026-05-12 | Heart rate | 78 /min | 8867-4 | S |
| 2026-05-12 | Respiratory rate | 16 /min | 9279-1 | S |
| 2026-05-12 | Body temperature | 36.7 Cel | 8310-5 | S |
| 2026-05-12 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 % | 59408-5 | S |
| 2026-05-26 | Body height | 165 cm | 8302-2 | S |
| 2026-05-26 | Body weight | 74.4 kg | 29463-7 | S |
| 2026-05-26 | Body mass index (BMI) [Ratio] | 27.3 kg/m2 | 39156-5 | S |
| 2026-05-26 | Systolic blood pressure | 148 mm[Hg] | 8480-6 | S |
| 2026-05-26 | Diastolic blood pressure | 92 mm[Hg] | 8462-4 | S |
| 2026-05-26 | Heart rate | 74 /min | 8867-4 | S |
| 2026-05-26 | Respiratory rate | 16 /min | 9279-1 | S |
| 2026-05-26 | Body temperature | 36.6 Cel | 8310-5 | S |
| 2026-05-26 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 % | 59408-5 | S |
| 2026-06-30 | Body height | 165 cm | 8302-2 | S |
| 2026-06-30 | Body weight | 74 kg | 29463-7 | S |
| 2026-06-30 | Body mass index (BMI) [Ratio] | 27.2 kg/m2 | 39156-5 | S |
| 2026-06-30 | Systolic blood pressure | 136 mm[Hg] | 8480-6 | S |
| 2026-06-30 | Diastolic blood pressure | 86 mm[Hg] | 8462-4 | S |
| 2026-06-30 | Heart rate | 72 /min | 8867-4 | S |
| 2026-06-30 | Respiratory rate | 14 /min | 9279-1 | S |
| 2026-06-30 | Body temperature | 36.6 Cel | 8310-5 | S |
| 2026-06-30 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 % | 59408-5 | S |
| 2026-08-25 | Body height | 165 cm | 8302-2 | S |
| 2026-08-25 | Body weight | 73.4 kg | 29463-7 | S |
| 2026-08-25 | Body mass index (BMI) [Ratio] | 27 kg/m2 | 39156-5 | S |
| 2026-08-25 | Systolic blood pressure | 124 mm[Hg] | 8480-6 | S |
| 2026-08-25 | Diastolic blood pressure | 78 mm[Hg] | 8462-4 | S |
| 2026-08-25 | Heart rate | 68 /min | 8867-4 | S |
| 2026-08-25 | Respiratory rate | 14 /min | 9279-1 | S |
| 2026-08-25 | Body temperature | 36.6 Cel | 8310-5 | S |
| 2026-08-25 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 % | 59408-5 | S |
| 2026-10-27 | Body height | 165 cm | 8302-2 | S |
| 2026-10-27 | Body weight | 73 kg | 29463-7 | S |
| 2026-10-27 | Body mass index (BMI) [Ratio] | 26.8 kg/m2 | 39156-5 | S |
| 2026-10-27 | Systolic blood pressure | 122 mm[Hg] | 8480-6 | S |
| 2026-10-27 | Diastolic blood pressure | 76 mm[Hg] | 8462-4 | S |
| 2026-10-27 | Heart rate | 66 /min | 8867-4 | S |
| 2026-10-27 | Respiratory rate | 14 /min | 9279-1 | S |
| 2026-10-27 | Body temperature | 36.5 Cel | 8310-5 | S |
| 2026-10-27 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 % | 59408-5 | S |
| 2026-07-28 | Body height | 165 cm | 8302-2 | S |
| 2026-07-28 | Body weight | 73.6 kg | 29463-7 | S |
| 2026-07-28 | Body mass index (BMI) [Ratio] | 27 kg/m2 | 39156-5 | S |
| 2026-07-28 | Systolic blood pressure | 142 mm[Hg] | 8480-6 | S |
| 2026-07-28 | Diastolic blood pressure | 88 mm[Hg] | 8462-4 | S |
| 2026-07-28 | Heart rate | 72 /min | 8867-4 | S |
| 2026-07-28 | Respiratory rate | 14 /min | 9279-1 | S |
| 2026-07-28 | Body temperature | 36.6 Cel | 8310-5 | S |
| 2026-07-28 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 % | 59408-5 | S |
| 2026-07-21 | Body height | 165 cm | 8302-2 | S |
| 2026-07-21 | Body weight | 72.6 kg | 29463-7 | S |
| 2026-07-21 | Body mass index (BMI) [Ratio] | 26.7 kg/m2 | 39156-5 | S |
| 2026-07-21 | Systolic blood pressure | 112 mm[Hg] | 8480-6 | S |
| 2026-07-21 | Diastolic blood pressure | 70 mm[Hg] | 8462-4 | S |
| 2026-07-21 | Heart rate | 104 /min | 8867-4 | S |
| 2026-07-21 | Respiratory rate | 16 /min | 9279-1 | S |
| 2026-07-21 | Body temperature | 37.2 Cel | 8310-5 | S |
| 2026-07-21 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 % | 59408-5 | S |
Social, functional, and mental status
Social history
- S Referee of professional boxing several nights a week, usually working a whole card of six to eight bouts, and a boxing instructor at a city college; a former world lightweight champion who served in the merchant marine in wartime
- S Lost most of his savings in a market crash years ago and went back to fighting to rebuild them; money is steady now but tight; worries that a failed license examination would cost him his refereeing work; asked for low-cost medicines
- S Jewish; raised in an Orthodox family on the Lower East Side; keeps the major holidays, and asked that visits not be booked on them
- S Never smoked; a glass of wine on the Sabbath and holidays (AUDIT-C 2); no drug use
- S Walks a great deal and moves constantly in the ring on fight nights, but does no other regular exercise since he stopped training; eats late after fights, often salted deli meats, pickles and soup
- S Strengths: quick, disciplined and well informed; a respected figure in boxing with many friends; steady work; wants to keep refereeing and teaching
Functional status
- S Independent and working; climbs three flights of stairs without stopping; breathless and tight in the chest only late in long cards in hot arenas
Mental status
- S Alert, articulate and good-humored, with quick wit; worried about money and his license; PHQ-9 5 with item 9 scored 0; GAD-7 6
Allergies and medications
Allergies
- S No known allergy
Medications
- S Losartan 50 mg with hydrochlorothiazide 12.5 mg, one tablet each morning
- S Losartan 100 mg with hydrochlorothiazide 25 mg, one tablet each morning
- S Atorvastatin 40 mg tablet, one each evening
- S Losartan 100 mg tablet, one each morning
- S Amlodipine 5 mg tablet, one each morning
Procedures and immunizations
Procedures
- S Resting 12-lead ECG: sinus rhythm at 78 per minute; left ventricular hypertrophy by voltage (Sokolow-Lyon 38 mm, Cornell 24 mm) with mild lateral T-wave flattening; PR 160 ms; QRS 96 ms; QTc 418 ms; no Q waves, pre-excitation, conduction block or Brugada pattern
- S Transthoracic echocardiogram: concentric left ventricular hypertrophy (septum 13 mm, posterior wall 12 mm, septal-to-posterior ratio 1.1, mass index 118 g/m2); ejection fraction 62% without regional wall motion abnormality; grade 1 diastolic dysfunction; left atrial volume index 36 mL/m2; no systolic anterior motion of the mitral valve or outflow tract obstruction at rest or with Valsalva; normal valves; aortic root 34 mm
- S Exercise stress echocardiogram (Bruce protocol): 9 minutes 30 seconds, about 10.5 METs; peak heart rate 156 per minute (92% of predicted); blood pressure 150/92 at rest rising to 226/98 mmHg at peak, an exaggerated response; mild breathlessness at peak without chest discomfort; no ST-segment change; no arrhythmia; normal augmentation of all wall segments, with no inducible ischemia
- S Noncontrast CT of the heart for coronary calcium: Agatston score 186 (left anterior descending 118, right coronary 52, circumflex 16), about the 80th percentile for his age and sex; no other cardiac finding
- S Resting 12-lead ECG at the sick visit: sinus tachycardia at 104 per minute; left ventricular hypertrophy by voltage, unchanged; QTc 432 ms; no ischemic change or arrhythmia
- S Advance care planning conversation, about 15 minutes, with his consent
Immunizations
- S 2026-07-28: Pneumococcal conjugate vaccine PCV20, single dose, recommended for all adults 50 and older
- S 2026-07-28: Recombinant zoster vaccine, dose 1 of 2
- S 2026-08-25: Hepatitis B vaccine (HepB-CpG), dose 1 of 2, after a screening panel showed no immunity
- S 2026-10-27: Hepatitis B vaccine (HepB-CpG), dose 2 of 2
- S 2026-10-27: Recombinant zoster vaccine, dose 2 of 2
- S 2026-10-27: Influenza vaccine, inactivated trivalent, this season's formulation
Past medical history
True biography with historical dates; not part of the synthetic care timeline.
Family history
No family medical history is documented in the logged sources. Family history of real relatives is never synthesized.
Care-plan goals
| Goal | Target date | Status | Outcome |
|---|---|---|---|
| Find the cause of the exertional breathlessness and chest tightness | 2026-05-26 | completed | No inducible ischemia; symptoms from hypertensive heart disease with an exaggerated blood pressure response |
| Blood pressure below 130/80 mmHg at home and in the clinic | 2026-08-25 | completed | 164/100 at intake to 124/78 in the clinic, home average 122/76 mmHg |
| LDL below 70 mg/dL and at least 50% lower than at intake | 2026-07-28 | completed | LDL 160 to 66 mg/dL (59% lower) on atorvastatin 40 mg |
| Keep refereeing full cards safely, without symptoms | 2027-05-12 | active | Back to full cards after the blood pressure fell; no symptoms since; a week off after the sick visit |
| Regression of left ventricular hypertrophy on a repeat echocardiogram | 2027-05-26 | active | Repeat echocardiogram due six to twelve months after the first |
Interventions
| Intervention | Status | Guideline |
|---|---|---|
| High blood pressure: home monitoring with a validated upper-arm cuff, twice a day, with readings sent in weekly; single-pill losartan 50 mg with hydrochlorothiazide 12.5 mg from today, chosen as two first-line drugs for stage 2 hypertension and a low-cost generic; basic metabolic panel in two weeks; target below 130/80 mmHg; less salt (no more than 1,500 to 2,300 mg a day), the DASH pattern, and regular walking | completed | GL-AHA-HTN-2025, GL-CMID-2026 |
| Cardiology consultation for exertional breathlessness and chest tightness with left ventricular hypertrophy on the ECG: the cause, the type of hypertrophy, sudden cardiac death risk, coronary risk testing, and whether he can keep refereeing | completed | GL-CHESTPAIN-2021, GL-AHA-HTN-2025, GL-AHA-CCD-2023 |
| Evaluation at intake: resting ECG, basic metabolic panel, TSH, HbA1c, lipid panel, one-time lipoprotein(a) and urine albumin-to-creatinine ratio; stop and rest, and call the same day for chest discomfort at rest or lasting more than a few minutes, fainting or palpitations; referee only short undercards until the consultation | completed | GL-AHA-HTN-2025, GL-CHESTPAIN-2021, GL-ACC-DYSLIP-2026 |
| Atorvastatin 40 mg each evening after a coronary calcium score of 186, aiming for LDL below 70 mg/dL and at least a 50% fall, with a lipid panel at eight to twelve weeks; aspirin discussed and not started while blood pressure is uncontrolled, to be revisited | completed | GL-ACC-DYSLIP-2026, GL-AHA-CCD-2023, GL-ACC-PREV-2019 |
| Return to work: short undercards until home blood pressure is below 140/90 mmHg, then full cards; drink water between bouts in hot arenas; stop and hand over the bout for chest discomfort, faintness or palpitations; hold the blood pressure tablet on sick days (vomiting, diarrhea, or unable to drink) and call; the venue to keep a defibrillator at ringside with staff trained in CPR; repeat echocardiogram in six to twelve months | completed | GL-ATHLETE-HTN-2015, GL-AHA-HTN-2025 |
| Losartan 100 mg with hydrochlorothiazide 25 mg each morning; basic metabolic panel two weeks after the increase | completed | GL-AHA-HTN-2025, GL-CMID-2026 |
| Volume depletion: oral fluids with salt and potassium-rich foods; hold losartan-hydrochlorothiazide until the recheck in one week; no refereeing until then; emergency care for fainting or chest pain | completed | GL-AHA-HTN-2025 |
| Change to losartan 100 mg and amlodipine 5 mg each morning, without the thiazide, because of heavy sweating in hot arenas; basic metabolic panel in four weeks; written sick-day rules on a card for his wallet | completed | GL-AHA-HTN-2025, GL-CMID-2026 |
| Money worries and mood: PHQ-9 and GAD-7 at intake and at six months; generic once-daily medicines at the lowest cost; a social needs screen; brief support and problem-solving at each visit | completed | GL-USPSTF-DEP-2023, GL-USPSTF-ANX-2023 |
Planned encounters
- 2026-05-12 — Establishing primary care at 50 after a referee's license examination found high blood pressure: exertional breathlessness and chest tightness while refereeing, an ECG showing left ventricular hypertrophy, cardiovascular risk, money worries and mood, and a cardiology consultation (ENC-001)
- 2026-05-26 — Two-week review on the day of the cardiology consultation: the echocardiogram, stress test and calcium score, home blood pressure, a statin, and refereeing (ENC-002)
- 2026-06-30 — Seven-week review: home blood pressure, the first weeks back at full cards, symptoms, and a dose increase (ENC-003)
- 2026-07-21 — Same-day sick visit for lightheadedness after refereeing in the heat (ENC-007, unscheduled)
- 2026-07-28 — Periodic adult preventive visit and recheck after the sick visit (ENC-006)
- 2026-08-25 — Fifteen-week review: blood pressure after the change of medicine, kidney function and potassium, cholesterol on the statin, and the sick visit (ENC-004)
- 2026-10-27 — Twenty-four-week review: blood pressure control, symptoms at work, mood and worry, aspirin, and the plan ahead (ENC-005)
Supporting documents
- History and physical
- Progress note 01
- Progress note 02 — Focused Visit (Follow-up)
- Progress note 03 — Focused Visit (Follow-up)
- Progress note 04 — Sick Visit
- Progress note 05 — Preventive Visit
- Progress note 06 — Focused Visit (Follow-up)
- Progress note 07 — Focused Visit (Care-plan review)
- Cardiology referral
- Cardiology consultation
- Patient care plan
- Teaching note
- Provenance CSV
C-CDA note documents
Each link opens a readable copy; the XML beside it is the exchange file.
- History and physical (XML)
- Progress note 01 (XML)
- Progress note 02 — Focused Visit (Follow-up) (XML)
- Progress note 03 — Focused Visit (Follow-up) (XML)
- Progress note 04 — Sick Visit (XML)
- Progress note 05 — Preventive Visit (XML)
- Progress note 06 — Focused Visit (Follow-up) (XML)
- Progress note 07 — Focused Visit (Care-plan review) (XML)
- Cardiology referral (XML)
- Cardiology consultation (XML)
Sources
| ID | Source | Publisher | Type |
|---|---|---|---|
| SRC-0001 | Leonard, Benny (Scribner Encyclopedia of American Lives, Thematic Series: Sports Figures) | Encyclopedia.com (Charles Scribner's Sons) | biography |
| SRC-0002 | Wright S. Benny Leonard (Research Starters: Biography) | EBSCO | biography |
| SRC-0003 | Benny Leonard (Class of 1979) | International Jewish Sports Hall of Fame | other |
| SRC-0004 | Leonard, Benny (Boxing) | Jews in Sports Online (virtual museum) | other |
| SRC-0005 | Benny Leonard (Albert Davis Collection boxing exhibit) | H.J. Lutcher Stark Center for Physical Culture and Sports, The University of Texas at Austin | other |
| SRC-0006 | Greenspan B. The Long Last Night in the Ring for Benny Leonard. The New York Times, April 10, 1983 (reprinted by the International Boxing Research Organization) | International Boxing Research Organization (reprint of The New York Times) | primary |
| SRC-0007 | HISTMED Master Roster v3 | The Human Record project | other |
Review status
| Review | Status | Notes |
|---|---|---|
| schema validation | not_started | Run scripts/build.ps1 -Conformance. |
| clinical review | not_started | Awaiting clinician review; check the stress echocardiogram as the test for exertional symptoms, hypertensive hypertrophy against hypertrophic cardiomyopathy, the sudden cardiac death risk discussion without Holter monitoring or a defibrillator, the calcium score and statin intensity, aspirin deferred, the single-pill start and titration, the missed potassium and creatinine check after the dose increase, the thiazide in summer heat and the change to amlodipine, and the return-to-work plan for refereeing. |
| provenance review | not_started | Sources: the Scribner Encyclopedia of American Lives (Encyclopedia.com), EBSCO Research Starters, the International Jewish Sports Hall of Fame, Jews in Sports Online, the Stark Center at the University of Texas at Austin, and Bud Greenspan's 1983 New York Times eyewitness account as reprinted by the International Boxing Research Organization. The contemporary New York Times obituary could not be fetched. The cause of death is disputed (heart attack in most sources, cerebral hemorrhage in one) and is graded R; no earlier heart disease is documented. |
| safe messaging review | not_started | His Jewish identity and the antisemitism of his era are recorded as documented history and with respect; the modern episode notes only that visits avoid the major holidays. His parents appear only in documented history claims; no relative has a role, statement, decision or health fact in the modern episode, and the family history is empty. His death in the ring is recorded on the timeline only; the modern episode makes no claim about its cause. PHQ-9 5 and 2, item 9 scored 0, so no safety assessment is required. |
Comments and corrections
Sign in with GitHub to comment on this record. To report a specific error, ideally with a source, use the feedback form; each report becomes a tracked issue.
Comments appear on the online version of this page.